Smith, Moore & Co. Johnson & Johnson Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Smith, Moore & Co. holds 24,090 shares of JNJ stock, worth $3.51 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

24,090

Previous 24,878 3.17%

Holding current value

$3.51 Million

Previous $3.64 Million 7.37%

% of portfolio

0.38%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $114,638 - $131,895	-788 Reduced 3.17%	24,090 $3.9 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $73,922 - $80,783	512 Added 2.1%	24,878 $3.64 Million
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $128,677 - $134,911	-829 Reduced 3.29%	24,366 $3.85 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $96,532 - $105,337	-663 Reduced 2.56%	25,195 $3.95 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $222,411 - $249,157	1,428 Added 5.85%	25,858 $4.03 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $62,357 - $67,108	404 Added 1.68%	24,430 $4.04 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $53,018 - $63,271	351 Added 1.48%	24,026 $3.72 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $16,500 - $18,518	103 Added 0.44%	23,675 $4.18 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $21,940 - $24,414	-136 Reduced 0.57%	23,572 $3.85 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $78,376 - $86,680	-466 Reduced 1.93%	23,708 $4.21 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $32,418 - $36,815	205 Added 0.86%	24,174 $4.28 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $27,599 - $30,622	177 Added 0.74%	23,969 $4.1 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $72,029 - $80,043	-446 Reduced 1.84%	23,792 $3.84 Million
Q2 2021 Aug 10, 2021	BUY	$159.48 - $171.07 $6,857 - $7,356	43 Added 0.18%	24,238 $4.01 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $101,791 - $113,369	665 Added 2.83%	24,195 $3.98 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $93,509 - $107,333	-682 Reduced 2.82%	23,530 $3.68 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $592,543 - $649,316	4,221 Added 21.11%	24,212 $3.6 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $438,082 - $528,889	-3,401 Reduced 14.54%	19,991 $2.79 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $130,589 - $180,938	-1,175 Reduced 4.78%	23,392 $3.07 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $22,822 - $26,212	-179 Reduced 0.72%	24,567 $3.58 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $196,645 - $220,174	-1,549 Reduced 5.89%	24,746 $3.2 Million
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $24,787 - $27,261	-189 Reduced 0.71%	26,295 $3.66 Million
Q1 2019 May 07, 2019	SELL	$125.72 - $139.79 $444,545 - $494,297	-3,536 Reduced 11.78%	26,484 $3.72 Million
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $230,693 - $277,643	-1,878 Reduced 5.89%	30,020 $3.87 Million
Q3 2018 Nov 15, 2018	BUY	$121.58 - $142.88 $153,069 - $179,885	1,259 Added 4.11%	31,898 $4.44 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $84,177 - $92,890	705 Added 2.36%	30,639 $3.72 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $56,545 - $66,959	-452 Reduced 1.49%	29,934 $3.84 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $64,560 - $70,661	-492 Reduced 1.59%	30,386 $4.25 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $4 Million - $4.18 Million	30,878	30,878 $4.01 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account